Oric Pharmaceuticals, Inc. Common Stock ORIC
$11.31
-4.23%
at last close
Analyst Consensus
- Consensus Rating
- Buy (11 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $21.27
- Implied Upside
- +88.1%
- Price Target Range
- $15.00 – $27.00
- Analysts (12 mo)
- 12
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-05 | Leerink PartnersAsthika Goonewardene |
Initiates coverage on | Outperform | $26 |
| 2026-09-23 | BTIGJeet Mukherjee |
Initiates coverage on | Buy | $26 |
| 2026-08-10 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $25 → $27 |
| 2026-06-08 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $25 |
| 2026-05-15 | Goldman SachsCorinne Johnson |
Upgrades | Buy | $15 |
| 2026-05-05 | CitigroupYigal Nochomovitz |
Maintains | Buy | $17 → $16 |
| 2026-04-02 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $25 |
| 2026-04-01 | WedbushDavid Nierengarten |
Maintains | Outperform | $20 → $17 |
| 2026-03-13 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $25 |
| 2026-02-24 | CitigroupYigal Nochomovitz |
Maintains | Buy | $16 → $17 |
| 2026-02-24 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $23 → $25 |
| 2026-02-24 | WedbushDavid Nierengarten |
Reiterates | Outperform | $20 |
| 2026-01-13 | WedbushDavid Nierengarten |
Reiterates | Outperform | $20 |
| 2026-01-07 | Piper SandlerKelsey Goodwin |
Initiates coverage on | Overweight | $22 |
| 2025-12-08 | Wells FargoDerek Archila |
Maintains | Overweight | $19 → $25 |
| 2025-12-08 | WedbushDavid Nierengarten |
Reiterates | Outperform | $20 |
| 2025-11-20 | Evercore ISI GroupCory Kasimov |
Initiates coverage on | Outperform | $25 |
| 2025-11-18 | Wolfe ResearchKalpit Patel |
Initiates coverage on | Peer perform | — |
| 2025-11-18 | JP MorganAnupam Rama |
Maintains | Overweight | $17 → $20 |
| 2025-11-17 | CitigroupYigal Nochomovitz |
Maintains | Buy | $12 → $16 |
| 2025-11-14 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $19 → $23 |
| 2025-11-14 | Wells FargoDerek Archila |
Maintains | Overweight | $20 → $19 |
| 2025-11-14 | OppenheimerMatthew Biegler |
Maintains | Outperform | $12 → $15 |
| 2025-09-04 | GuggenheimBrad Canino |
Assumes | Buy | $18 |
| 2025-08-14 | JP MorganAnupam Rama |
Maintains | Overweight | $20 → $17 |
| 2025-08-14 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $22 → $19 |
| 2025-08-13 | GuggenheimMichael Schmidt |
Reiterates | Buy | $18 |
| 2025-07-08 | Ladenburg ThalmannKevin DeGeeter |
Initiates coverage on | Buy | $15 |
| 2025-05-09 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $21 → $22 |
| 2025-05-06 | OppenheimerMatthew Biegler |
Maintains | Outperform | $15 → $12 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $11.31
- Market Cap
- $1.22 billion
- 52-Week Range
- $7.23 – $14.93
- Average Volume
- 1.47 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.